As the EU Medical Device Regulation (MDR) deadline has passed, medical device manufacturers must explore alternative avenues to sell their devices abroad. Leveraging schemes such as MDSAP, Swissmedic, and UKCA in conjunction with ISO 13485, can facilitate market access in various regions.
This presentation describes options available to manufacturers who wish to access markets other than the EU.
Strategies that will be helpful in navigating the following options:
- Medical Device Single Audit Program (MDSAP): MDSAP is a program that enables medical device manufacturers to undergo a single audit to satisfy the regulatory requirements of multiple jurisdictions, including the United States, Canada, Australia, Brazil, and Japan; with a combined population of 733 million.
- UKCA Marking: Following Brexit, the United Kingdom (UK) introduced its own regulatory framework for medical devices, known as the UK Conformity Assessed (UKCA) marking. This entails conformity assessment by a UK Approved Body.
- Swissmedic Approval: Following the non-renewal of the Mutual Recognition Agreement (MRA) between the EU and Switzwerland, to sell medical devices in Switzerland, manufacturers must obtain approval from Swissmedic - the Swiss Agency for Therapeutic Products. Swissmedic evaluates medical devices based on safety, efficacy, and quality standards before granting market authorization.